SHC (Sotera Health Co) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHC Sotera Health Co SHC
73 GF Score
Price $18.16
GF Value $16.35
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sotera Health Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHC
73GF Score
Sotera Health Co SHC
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $18.16 is trading 11% above its estimated GF Value™ of $16.35. GuruFocus considers Sotera Health Co to be Modestly Overvalued.

Key valuation signals for SHC:

  • Interest Received:
  • GF Value™: $16.35 vs. price of $18.16 (11% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
73GF Score

Get the complete analysis for SHC

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.16
Price
$16.35
GF Value